Advanced Search

The American Journal of Psychiatry, VOL. 163, No. 3

Letter to the Editor | March 01, 2006

BIJU BASIL, M.D.; MAJU MATHEWS, M.D., M.R.C.Psych.; BABATUNDE ADETUNJI, M.D.; KUMAR BUDUR, M.D.

Am J Psychiatry 2006;163:555-555. 10.1176/appi.ajp.163.3.555

Article

Tables

References

text A A A

To the Editor:

As reported in the CATIE study, atypical antipsychotics account for more than 90% of the market share. We did a cost comparison of 1 month’s supply of the various antipsychotic drugs in the study on the online purchase site of a chain pharmacy to check for most recent prices (Table 1). The prices were checked on Sept. 28, 2005. This particular pharmacy was chosen because a majority of the patients we see fill their prescriptions there.

The cost of "typical" antipsychotics (haloperidol and perphenazine) is just a fraction of that of atypical antipsychotics. Typical antipsychotics have been shown to be as effective as quetiapine, risperidone, and ziprasidone in the CATIE study. Based on the study findings and the cost comparison, we contend that the cheaper, more effective typical antipsychotics should have been considered in patients not able to afford the costlier atypical antipsychotics. But this should have been done as stated in the editorial on the basis of clinical judgment and informed patient preference (1).

TABLE 1

View Large | Download Slide(.ppt)
Add to My POL

References

Freedman R: The choice of antipsychotic drugs for schizophrenia (editorial). N Engl J Med 2005; 353:1286–1288[PubMed][CrossRef]

TABLE 1

View Large | Download Slide(.ppt)
Add to My POL

Freedman R: The choice of antipsychotic drugs for schizophrenia (editorial). N Engl J Med 2005; 353:1286–1288[PubMed][CrossRef]

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.

Submit a Comments

Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

* = Required Field

Comment Author(s)*(if multiple authors, separate names by comma)

Example: John Doe

Affiliation & Institution*

Comment Title*

Comment*

Cancel

Print
PDF
E-mail

Recipient(s) will receive an email with a link (good for 72 hours) to '' and do not need to have American Journal of Psychiatry account to access the content.
Your Name:*
Example: John Doe

Email Address:* CC Me:
Enter your valid email address. Example: jdoe@example.com

Recipient's Email Address:*
Separate multiple email address with semi-colons (up to 5).

Subject:* 's American Journal of Psychiatry: ''
Subject for your email.

Message:
(Optional, message will truncate at 1000 characters)

Processing your request... Please Wait...

Copyright © in the material you requested is held by The American Psychiatric Association (unless otherwise noted). This email ability is provided as a courtesy, and by using it you agree that you are requesting the material solely for personal, non-commercial use, and that it is subject to The American Psychiatric Association's Terms of Use. The information provided in order to email this topic will not be used to send unsolicited email, nor will it be furnished to third parties. Please refer to The American Psychiatric Association's Privacy Policy for further information.

Copyright © American Psychiatric Association. All rights reserved.
Share
Get Citation

BIJU BASIL, MAJU MATHEWS, BABATUNDE ADETUNJI, KUMAR BUDUR; American Journal of Psychiatry. 2006 Mar;163(3):555-555.

Download citation file:

RIS (Zotero)

EndNote

BibTex

Medlars

ProCite

RefWorks

Reference Manager

Copyright © American Psychiatric Association. All rights reserved.
Reprints